Loading clinical trials...
Loading clinical trials...
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008: Cognition in Participants With Pyruvate Kinase Deficiency
Conditions
Locations
3
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
Start Date
July 2, 2021
Primary Completion Date
September 22, 2023
Completion Date
September 22, 2023
Last Updated
October 16, 2023
NCT05144256
NCT03481738
NCT02476916
NCT06422351
NCT04964323
NCT03866590
Lead Sponsor
Agios Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions